98%
921
2 minutes
20
Background & Aims: IL-15Rα mediates immune responses by binding and trans-presenting IL-15 to tissue-resident memory T (T) cells, enabling sustained activation. Given the pivotal role of IL-15Rα/IL-15 signaling in autoimmune diseases, elucidating its organ-specific expression and pathogenic functions in primary biliary cholangitis (PBC) remains crucial.
Methods: Immunohistochemical staining was performed on liver tissues from patients with PBC (n=94), AIH (n=32), CHB (n=10), NASH (n=7) and HCs (n=10) to assess IL-15Rα expression. Flow cytometric analysis characterized intrahepatic IL-15Rα B cells and CD4 T cells .RNA-Seq was employed to delineate the transcriptomic signatures of in vitro-induced B cells and intrahepatic leukocytes. To investigate the cytotoxicity of T cells against cholangiocytes, we performed organoid co-culture system. Moreover, dnTGFβRII mice treated with anti-IL-15/IL-15Rα mAb were used for in-vivo validation.
Results: IL-15Rα cells were significantly increased in PBC patients, primarily concentrated within the plasmablast B cell population, and positively correlated with hepatic inflammation severity. IL-15Rα B cells enriched around bile ducts in PBC livers secrete CCL3 to recruit CCR5CD4 T cells, enhancing their effector functions via IL-15Rα/IL-15 signaling. Notably, CCR5CD4 T cells drive cholangiocyte pyroptosis through granzyme A-mediated GSDMB cleavage. Furthermore, blockade of IL-15Rα/IL-15 signaling ameliorates liver injury in PBC mouse models.
Conclusions: Our findings reveal an important pathogenic mechanism in PBC wherein IL-15Rα B cells contribute to biliary injury by activating CCR5CD4 T cells. This mechanism likely works in concert with other immune effector pathways in driving disease progression.
Impact And Implications: This study reveals that IL-15Rα-expressing B cells manifest a pro-inflammatory phenotype and promote biliary injury by impairing immune homeostasis through aberrant activation of tissue-resident memory T cells during PBC progression. Although we now offer a new paradigm how IL-15 trans-presentation is regulated in a B cell-dependent manner in PBC, the regulatory effects of IL-15Rα/IL-15 signaling on other chronic liver diseases remain to be further elucidated.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jhep.2025.06.037 | DOI Listing |
Cancer Immunol Res
September 2025
QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Natural killer (NK) cell licensing is an educational process that enhances responsiveness to activating signals in maturing NK cells and is predominantly regulated by major histocompatibility complex (MHC) class I-specific inhibitory signals. However, the role of non-MHC signalling in this process remains unclear. Here, we investigated the role of FcRγ, an adaptor protein associated with activating receptors, in the regulation of NK cell responsiveness.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33125, USA.
Interleukin (IL)-15 is primarily known as a pro-inflammatory and anti-apoptotic cytokine, which stimulates the proliferation and survival of key immunocytes, including macrophages (MACs). Yet, it remains unclear how IL-15 specifically impacts MACs in intact human skin, particularly immunoinhibitory, IL-10-producing/secreting M2 MACs (CD206IL-10). In the current pilot study, we explored this in organ-cultured healthy human eyelid skin in the presence of IFNγ (100 IU/mL) to mimic a pro-inflammatory signaling milieu found in several chronic immunodermatoses.
View Article and Find Full Text PDFBiomedicines
August 2025
Concept Life Sciences, Edinburgh EH16 4UX, UK.
Immune checkpoint inhibitor therapy in patients with lung cancer and metastatic melanoma is associated with exacerbation of autoimmune-related diseases. The efficacy of treatment targeting the programmed cell death receptor-1 (PD-1) checkpoint relies upon a feedback loop between interferon gamma (IFN-γ) and the interleukin-12 isoform, IL-12p40. Paradoxically, both cytokines and the anti-PD-1 antibody worsen psoriasis.
View Article and Find Full Text PDFCancer Res
August 2025
University College London, London, United Kingdom.
γδ T cells can kill cancer cells via antibody-independent cytotoxicity (AIC) and antibody-dependent cellular cytotoxicity (ADCC). A better understanding of how these cytotoxic mechanisms are impacted by different cancer cells and different T cell donors could help identify improved immunotherapeutic strategies. To test the combinatorial interactions between T cell inter-donor heterogeneity (IDH), cancer cell inter-tumor heterogeneity (ITH), and multimodal γδ T cell killing, we performed a systematic single-cell phenoscaping analysis of >1,000 cultures of γδ T cells and colorectal cancer (CRC) patient-derived organoids (PDO).
View Article and Find Full Text PDFBiochem Biophys Res Commun
August 2025
Henan Engineering Technology Research Center for Advanced SynBio Medicine and Clinical Innovation Translation, School of Life Sciences and Technology, Henan Medical University, Xinxiang, Henan Province, PR China; Henan Engineering Research Center of Innovation for Synthetic Biology, School of Life S
Chimeric antigen receptor (CAR)-engineered natural killer (NK) cells hold promise for off-the-shelf cancer immunotherapy, yet their clinical application is hindered by poor persistence due to cytokine dependency and systemic toxicity from exogenous cytokine support. Here, we developed membrane-bound cytokine (mbCytokine) modules to enable autonomous survival signaling in CAR-NK cells. By fusing IL-2, IL-15, or the potent mimic Neo-2/15 to their cognate receptor α-chains (IL-2Rα or IL-15Rα), we generated self-sustaining CAR-NK92 cells that bypass reliance on external cytokines.
View Article and Find Full Text PDF